SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001328143-19-000013
Filing Date
2019-03-04
Accepted
2019-03-04 16:38:23
Documents
4
Effectiveness Date
2019-03-04

Document Format Files

Seq Description Document Type Size
1 S-8 admss-82019filing.htm S-8 105117
2 EXHIBIT 5.1 admss-8ex51.htm EX-5.1 10071
3 EXHIBIT 23.1 admss-8ex231.htm EX-23.1 2529
4 cooleyl.jpg GRAPHIC 10498
  Complete submission text file 0001328143-19-000013.txt   127984
Mailing Address 1900 POWELL ST., SUITE 1000 EMERYVILLE CA 94608
Business Address 1900 POWELL ST., SUITE 1000 EMERYVILLE CA 94608 510-450-3554
Adamas Pharmaceuticals Inc (Filer) CIK: 0001328143 (see all company filings)

IRS No.: 421560076 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-230058 | Film No.: 19654326
SIC: 2834 Pharmaceutical Preparations